Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Subcutaneous Immunoglobulins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Global Subcutaneous Immunoglobulins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Industry: Pharma & Healthcare

Published Date: 2025-03-28

Pages: 113 Pages

Report ld: 4675490

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Subcutaneous Immunoglobulins Market Size(US$)

CAGR 2025-2031

12.1%

Market Size,2031

USD 12,050

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 6,087 million

Market Forecast in 2031(Value)

US$ 12,050 million

CAGR

12.1%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

In 2024, the global market size of Subcutaneous Immunoglobulins was estimated to be worth US$ 5491 million and is forecast to reach approximately US$ 12050 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).

In United States, Subcutaneous Immunoglobulins key players include Shire (Baxalta), Grifols, etc. Global top two manufacturers hold a share over 90%.

South is the largest market, with a share about 35%, followed by West, and Northeast, both have a share about 45 percent.

In terms of product, 10% Purity is the largest segment, with a share over 75%. And in terms of application, the largest application is Primary Immunodeficiency, followed by Secondary Immunodeficiency, etc.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Subcutaneous Immunoglobulins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Immunoglobulins.

The Subcutaneous Immunoglobulins market size, estimations, and forecasts are provided in terms of sales volume (K Bottle) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Subcutaneous Immunoglobulins market comprehensively. Regional market sizes, concerning products by Purity, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Subcutaneous Immunoglobulins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Purity, by Application, and regions.

By Company

Shire (Baxalta)

Grifols

CSL

Segment by Purity

0.1

0.2

Segment by Application

Primary Immunodeficiency

Secondary Immunodeficiency

Others

By Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Rest of Europe

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Purity and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Subcutaneous Immunoglobulins in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 3: Detailed analysis of Subcutaneous Immunoglobulins manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Subcutaneous Immunoglobulins sales, revenue, price, gross margin, sales by region, by Purity, by Application, and recent development, etc.

Chapter 5: Provides the analysis of various market segments by Purity, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America by Purity, by Application and by country, sales, and revenue for each segment.

Chapter 8: APAC by Purity, by Application and by country, sales, and revenue for each segment.

Chapter 9: Europe by Purity, by Application and by country, sales, and revenue for each segment.

Chapter 10: Latin America by Purity, by Application and by country, sales, and revenue for each segment.

Chapter 11: Middle East and Africa by Purity, by Application and by country, sales, and revenue for each segment.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: Research Findings and Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Subcutaneous Immunoglobulins Product Introduction

1.2 Market by Purity

1.2.1 Global Subcutaneous Immunoglobulins Market Size Growth Rate by Purity (2020 VS 2024 VS 2031)

1.2.2 0.1

1.2.3 0.2

1.3 Market by Application

1.3.1 Global Subcutaneous Immunoglobulins Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Primary Immunodeficiency

1.3.3 Secondary Immunodeficiency

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Subcutaneous Immunoglobulins Market Size Estimates and Forecasts

2.1.1 Global Subcutaneous Immunoglobulins Revenue 2020-2031

2.1.2 Global Subcutaneous Immunoglobulins Sales 2020-2031

2.2 Subcutaneous Immunoglobulins Market Size by Region: 2024 Versus 2031

2.3 Subcutaneous Immunoglobulins Sales by Region (2020-2031)

2.3.1 Global Subcutaneous Immunoglobulins Sales by Region: 2020-2025

2.3.2 Global Subcutaneous Immunoglobulins Sales Forecast by Region (2026-2031)

2.3.3 Global Subcutaneous Immunoglobulins Sales Market Share by Region (2020-2031)

2.4 Subcutaneous Immunoglobulins Market Estimates and Projections by Region (2026-2031)

2.4.1 Global Subcutaneous Immunoglobulins Revenue by Region: 2020-2025

2.4.2 Global Subcutaneous Immunoglobulins Revenue Forecast by Region (2026-2031)

2.4.3 Global Subcutaneous Immunoglobulins Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Purity

3.1.1 Global Subcutaneous Immunoglobulins Sales by Purity (2020-2031)

3.1.1.1 Global Subcutaneous Immunoglobulins Sales Volume by Purity (2020-2031)

3.1.1.2 Global Subcutaneous Immunoglobulins Sales Market Share by Purity (2020-2031)

3.1.2 Global Subcutaneous Immunoglobulins Revenue by Purity (2020-2031)

3.1.2.1 Global Subcutaneous Immunoglobulins Revenue by Purity (2020-2031)

3.1.2.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Purity (2020-2031)

3.1.3 Subcutaneous Immunoglobulins Average Selling Price (ASP) by Purity (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Subcutaneous Immunoglobulins Sales by Application (2020-2031)

3.2.1.1 Global Subcutaneous Immunoglobulins Sales Volume by Application (2020-2031)

3.2.1.2 Global Subcutaneous Immunoglobulins Sales Market Share by Application (2020-2031)

3.2.2 Global Subcutaneous Immunoglobulins Revenue by Application (2020-2031)

3.2.2.1 Global Subcutaneous Immunoglobulins Revenue by Application (2020-2031)

3.2.2.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Application (2020-2031)

3.2.3 Subcutaneous Immunoglobulins Average Selling Price (ASP) by Application (2020-2031)

3.3 by Purity and by Application Crossing Analysis

3.3.1 0.1 of Subcutaneous Immunoglobulins Revenue Market Share by Application

3.3.2 0.2 of Subcutaneous Immunoglobulins Revenue Market Share by Application

4 Global Subcutaneous Immunoglobulins by Manufacturers

4.1 Global Top Subcutaneous Immunoglobulins Manufacturers by Sales (2020-2025)

4.1.1 Global Subcutaneous Immunoglobulins Sales by Manufacturer (2020-2025)

4.1.2 Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturer (2020-2025)

4.2 Global Top Subcutaneous Immunoglobulins Manufacturers by Revenue (2020-2025)

4.2.1 Global Subcutaneous Immunoglobulins Revenue by Manufacturer (2020-2025)

4.2.2 Global Subcutaneous Immunoglobulins Revenue Share by Manufacturer (2020-2025)

4.3 Global Subcutaneous Immunoglobulins Price by Manufacturer (2020-2025)

4.4 Competitive Landscape

4.4.1 Key Subcutaneous Immunoglobulins Manufacturers Covered: Ranking by Revenue

4.4.2 Global Subcutaneous Immunoglobulins Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.4.3 Global Subcutaneous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5 Global Subcutaneous Immunoglobulins Manufacturing Base Distribution, Product Type

4.5.1 Subcutaneous Immunoglobulins Manufacturers Manufacturing Base Distribution, Headquarters

4.5.2 Date of International Manufacturers Enter into Subcutaneous Immunoglobulins Market

4.5.3 Manufacturers Subcutaneous Immunoglobulins Product Type and Application

4.5.4 0.1 Market Sales of Subcutaneous Immunoglobulins by Manufacturer

4.5.5 0.2 Market Sales of Subcutaneous Immunoglobulins by Manufacturer

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Shire (Baxalta)

5.1.1 Shire (Baxalta) Company Information

5.1.2 Shire (Baxalta) Description, Business Overview

5.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Products Offered

5.1.4 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)

5.1.5 Shire (Baxalta) Subcutaneous Immunoglobulins Sales by Product in 2024

5.1.6 Shire (Baxalta) Subcutaneous Immunoglobulins Sales by Application in 2024

5.1.7 Shire (Baxalta) Subcutaneous Immunoglobulins Sales by Geographic Area in 2024

5.1.8 Shire (Baxalta) Recent Developments

5.2 Grifols

5.2.1 Grifols Company Information

5.2.2 Grifols Description, Business Overview

5.2.3 Grifols Subcutaneous Immunoglobulins Products Offered

5.2.4 Grifols Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)

5.2.5 Grifols Subcutaneous Immunoglobulins Sales by Product in 2024

5.2.6 Grifols Subcutaneous Immunoglobulins Sales by Application in 2024

5.2.7 Grifols Subcutaneous Immunoglobulins Sales by Geographic Area in 2024

5.2.8 Grifols Recent Developments

5.3 CSL

5.3.1 CSL Company Information

5.3.2 CSL Description, Business Overview

5.3.3 CSL Subcutaneous Immunoglobulins Products Offered

5.3.4 CSL Subcutaneous Immunoglobulins Sales, Revenue and Gross Margin (2020-2025)

5.3.5 CSL Subcutaneous Immunoglobulins Sales by Product in 2024

5.3.6 CSL Subcutaneous Immunoglobulins Sales by Application in 2024

5.3.7 CSL Subcutaneous Immunoglobulins Sales by Geographic Area in 2024

5.3.8 CSL Recent Developments

6 North America

6.1 North America Subcutaneous Immunoglobulins Market Size YoY Growth 2020-2031

6.2 North America Subcutaneous Immunoglobulins Market Facts & Figures by Country

6.2.1 North America Subcutaneous Immunoglobulins Sales by Country (2020-2031)

6.2.2 North America Subcutaneous Immunoglobulins Revenue by Country (2020-2031)

6.3 North America Subcutaneous Immunoglobulins Sales by Purity (2020-2025)

6.4 North America Subcutaneous Immunoglobulins Sales by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Subcutaneous Immunoglobulins Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Subcutaneous Immunoglobulins Market Facts & Figures by Region

7.2.1 Asia-Pacific Subcutaneous Immunoglobulins Sales by Region (2020-2031)

7.2.2 Asia-Pacific Subcutaneous Immunoglobulins Revenue by Region (2020-2031)

7.3 Asia-Pacific Subcutaneous Immunoglobulins Sales by Purity (2020-2025)

7.4 Asia-Pacific Subcutaneous Immunoglobulins Sales by Application (2020-2025)

8 Europe

8.1 Europe Subcutaneous Immunoglobulins Market Size YoY Growth 2020-2031

8.2 Europe Subcutaneous Immunoglobulins Market Facts & Figures by Country

8.2.1 Europe Subcutaneous Immunoglobulins Sales by Country (2020-2031)

8.2.2 Europe Subcutaneous Immunoglobulins Revenue by Country (2020-2031)

8.3 Europe Subcutaneous Immunoglobulins Sales by Purity (2020-2025)

8.4 Europe Subcutaneous Immunoglobulins Sales by Application (2020-2025)

9 Latin America

9.1 Latin America Subcutaneous Immunoglobulins Market Size YoY Growth 2020-2031

9.2 Latin America Subcutaneous Immunoglobulins Market Facts & Figures by Country

9.2.1 Latin America Subcutaneous Immunoglobulins Sales by Country (2020-2031)

9.2.2 Latin America Subcutaneous Immunoglobulins Revenue by Country (2020-2031)

9.3 Latin America Subcutaneous Immunoglobulins Sales by Purity (2020-2025)

9.4 Latin America Subcutaneous Immunoglobulins Sales by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Subcutaneous Immunoglobulins Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Subcutaneous Immunoglobulins Market Facts & Figures by Country

10.2.1 Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2020-2031)

10.2.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country (2020-2031)

10.3 Middle East and Africa Subcutaneous Immunoglobulins Sales by Purity (2020-2025)

10.4 Middle East and Africa Subcutaneous Immunoglobulins Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Subcutaneous Immunoglobulins Supply Chain Analysis

11.2 Subcutaneous Immunoglobulins Key Raw Materials and Upstream Suppliers

11.3 Subcutaneous Immunoglobulins Clients Analysis

11.4 Subcutaneous Immunoglobulins Sales Channel and Sales Model Analysis

11.4.1 Subcutaneous Immunoglobulins Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Subcutaneous Immunoglobulins Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Subcutaneous Immunoglobulins Distributors

12 Subcutaneous Immunoglobulins Market Dynamics

12.1 Subcutaneous Immunoglobulins Industry Trends

12.2 Subcutaneous Immunoglobulins Market Drivers

12.3 Subcutaneous Immunoglobulins Market Challenges

12.4 Subcutaneous Immunoglobulins Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Subcutaneous Immunoglobulins Market Size Growth Rate by Purity (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Subcutaneous Immunoglobulins Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Subcutaneous Immunoglobulins Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Subcutaneous Immunoglobulins Sales by Region (2020-2025) & (K Bottle)

Table 5. Global Subcutaneous Immunoglobulins Sales Forecast by Region (2026-2031) & (K Bottle)

Table 6. Global Subcutaneous Immunoglobulins Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Subcutaneous Immunoglobulins Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Subcutaneous Immunoglobulins Sales Volume by Purity (2020-2025) & (K Bottle)

Table 9. Global Subcutaneous Immunoglobulins Sales Volume by Purity (2026-2031) & (K Bottle)

Table 10. Global Subcutaneous Immunoglobulins Revenue by Purity (2020-2025) & (US$ Million)

Table 11. Global Subcutaneous Immunoglobulins Revenue Forecast by Purity (2026-2031) & (US$ Million)

Table 12. Global Subcutaneous Immunoglobulins Sales Volume by Application (2020-2025) & (K Bottle)

Table 13. Global Subcutaneous Immunoglobulins Sales Volume by Application (2026-2031) & (K Bottle)

Table 14. Global Subcutaneous Immunoglobulins Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Subcutaneous Immunoglobulins Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Subcutaneous Immunoglobulins Sales by Manufacturer (2020-2025) & (K Bottle)

Table 17. Global Subcutaneous Immunoglobulins Sales Share by Manufacturer (2020-2025)

Table 18. Subcutaneous Immunoglobulins Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Subcutaneous Immunoglobulins Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Subcutaneous Immunoglobulins Price (2020-2025) & (USD/Bottle)

Table 21. Ranking of Global Top Subcutaneous Immunoglobulins Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Subcutaneous Immunoglobulins Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Subcutaneous Immunoglobulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Immunoglobulins as of 2024)

Table 24. Subcutaneous Immunoglobulins Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Subcutaneous Immunoglobulins Market

Table 26. Manufacturers Subcutaneous Immunoglobulins Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. Shire (Baxalta) Company Information

Table 29. Shire (Baxalta) Description and Business Overview

Table 30. Shire (Baxalta) Subcutaneous Immunoglobulins Product

Table 31. Shire (Baxalta) Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)

Table 32. Shire (Baxalta) Sales Proportion of Subcutaneous Immunoglobulins by Product in 2024

Table 33. Shire (Baxalta) Sales Proportion of Subcutaneous Immunoglobulins by Application in 2024

Table 34. Shire (Baxalta) Sales Proportion of Subcutaneous Immunoglobulins by Geographic Area in 2024

Table 35. Shire (Baxalta) Recent Developments

Table 36. Grifols Company Information

Table 37. Grifols Description and Business Overview

Table 38. Grifols Subcutaneous Immunoglobulins Product

Table 39. Grifols Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)

Table 40. Grifols Sales Proportion of Subcutaneous Immunoglobulins by Product in 2024

Table 41. Grifols Sales Proportion of Subcutaneous Immunoglobulins by Application in 2024

Table 42. Grifols Sales Proportion of Subcutaneous Immunoglobulins by Geographic Area in 2024

Table 43. Grifols Recent Developments

Table 44. CSL Company Information

Table 45. CSL Description and Business Overview

Table 46. CSL Subcutaneous Immunoglobulins Product

Table 47. CSL Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)

Table 48. CSL Sales Proportion of Subcutaneous Immunoglobulins by Product in 2024

Table 49. CSL Sales Proportion of Subcutaneous Immunoglobulins by Application in 2024

Table 50. CSL Sales Proportion of Subcutaneous Immunoglobulins by Geographic Area in 2024

Table 51. CSL Recent Developments

Table 52. North America Subcutaneous Immunoglobulins Sales by Country (2020-2025) & (K Bottle)

Table 53. North America Subcutaneous Immunoglobulins Sales by Country (2026-2031) & (K Bottle)

Table 54. North America Subcutaneous Immunoglobulins Revenue by Country (2020-2025) & (US$ Million)

Table 55. North America Subcutaneous Immunoglobulins Revenue by Country (2026-2031) & (US$ Million)

Table 56. North America Subcutaneous Immunoglobulins Sales by Purity (2020-2025) & (K Bottle)

Table 57. North America Subcutaneous Immunoglobulins Sales by Application (2020-2025) & (K Bottle)

Table 58. Asia-Pacific Subcutaneous Immunoglobulins Sales by Region (2020-2025) & (K Bottle)

Table 59. Asia-Pacific Subcutaneous Immunoglobulins Sales by Region (2026-2031) & (K Bottle)

Table 60. Asia-Pacific Subcutaneous Immunoglobulins Revenue by Region (2020-2025) & (US$ Million)

Table 61. Asia-Pacific Subcutaneous Immunoglobulins Revenue by Region (2026-2031) & (US$ Million)

Table 62. Asia-Pacific Subcutaneous Immunoglobulins Sales by Purity (2020-2025) & (K Bottle)

Table 63. Asia-Pacific Subcutaneous Immunoglobulins Sales by Application (2020-2025) & (K Bottle)

Table 64. Europe Subcutaneous Immunoglobulins Sales by Country (2020-2025) & (K Bottle)

Table 65. Europe Subcutaneous Immunoglobulins Sales by Country (2026-2031) & (K Bottle)

Table 66. Europe Subcutaneous Immunoglobulins Revenue by Country (2020-2025) & (US$ Million)

Table 67. Europe Subcutaneous Immunoglobulins Revenue by Country (2026-2031) & (US$ Million)

Table 68. Europe Subcutaneous Immunoglobulins Sales by Purity (2020-2025) & (K Bottle)

Table 69. Europe Subcutaneous Immunoglobulins Sales by Application (2020-2025) & (K Bottle)

Table 70. Latin America Subcutaneous Immunoglobulins Sales by Country (2020-2025) & (K Bottle)

Table 71. Latin America Subcutaneous Immunoglobulins Sales by Country (2026-2031) & (K Bottle)

Table 72. Latin America Subcutaneous Immunoglobulins Revenue by Country (2020-2025) & (US$ Million)

Table 73. Latin America Subcutaneous Immunoglobulins Revenue by Country (2026-2031) & (US$ Million)

Table 74. Latin America Subcutaneous Immunoglobulins Sales by Purity (2020-2025) & (K Bottle)

Table 75. Latin America Subcutaneous Immunoglobulins Sales by Application (2020-2025) & (K Bottle)

Table 76. Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2020-2025) & (K Bottle)

Table 77. Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2026-2031) & (K Bottle)

Table 78. Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country (2020-2025) & (US$ Million)

Table 79. Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country (2026-2031) & (US$ Million)

Table 80. Middle East and Africa Subcutaneous Immunoglobulins Sales by Purity (2020-2025) & (K Bottle)

Table 81. Middle East and Africa Subcutaneous Immunoglobulins Sales by Application (2020-2025) & (K Bottle)

Table 82. Subcutaneous Immunoglobulins Key Raw Materials, Industry Status and Trend

Table 83. Subcutaneous Immunoglobulins Key Raw Materials and Upstream Suppliers

Table 84. Subcutaneous Immunoglobulins Clients Status and Trend

Table 85. Subcutaneous Immunoglobulins Typical Clients

Table 86. Subcutaneous Immunoglobulins Distributors

Table 87. Subcutaneous Immunoglobulins Market Trends

Table 88. Subcutaneous Immunoglobulins Market Drivers

Table 89. Subcutaneous Immunoglobulins Market Challenges

Table 90. Subcutaneous Immunoglobulins Market Restraints

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

Table 94. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Subcutaneous Immunoglobulins Product Picture

Figure 2. Global Subcutaneous Immunoglobulins Market Size by Purity (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Subcutaneous Immunoglobulins Sales Market Share by Purity in 2024 & 2031

Figure 4. 0.1 Product Picture

Figure 5. 0.2 Product Picture

Figure 6. Global Subcutaneous Immunoglobulins Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 7. Global Subcutaneous Immunoglobulins Sales Market Share by Application in 2024 & 2031

Figure 8. Primary Immunodeficiency

Figure 9. Secondary Immunodeficiency

Figure 10. Others

Figure 11. Subcutaneous Immunoglobulins Report Years Considered

Figure 12. Global Subcutaneous Immunoglobulins Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Subcutaneous Immunoglobulins Market Size 2020-2031 (US$ Million)

Figure 14. Global Subcutaneous Immunoglobulins Sales 2020-2031 (K Bottle)

Figure 15. Global Subcutaneous Immunoglobulins Sales Market Share Forecast by Region (2020-2031)

Figure 16. Global Subcutaneous Immunoglobulins Revenue Market Share by Region (2020-2031)

Figure 17. Global Subcutaneous Immunoglobulins Sales Market Share Forecast by Purity (2020-2031)

Figure 18. Global Subcutaneous Immunoglobulins Revenue Market Share Forecast by Purity (2020-2031)

Figure 19. Subcutaneous Immunoglobulins Average Selling Price (ASP) by Purity (2020-2025) & (USD/Bottle)

Figure 20. Global Subcutaneous Immunoglobulins Sales Market Share Forecast by Application (2020-2031)

Figure 21. Global Subcutaneous Immunoglobulins Revenue Market Share Forecast by Application (2020-2031)

Figure 22. Subcutaneous Immunoglobulins Average Selling Price (ASP) by Application (2020-2025) & (USD/Bottle)

Figure 23. 0.1 of Subcutaneous Immunoglobulins Revenue Market Share by Application, 2024 VS 2031

Figure 24. 0.2 of Subcutaneous Immunoglobulins Revenue Market Share by Application, 2024 VS 2031

Figure 25. Global Subcutaneous Immunoglobulins Sales Share by Manufacturer in 2024

Figure 26. Subcutaneous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 27. 0.1 Market Sales Proportion by Manufacturer in 2024

Figure 28. 0.2 Market Sales Proportion by Manufacturer in 2024

Figure 29. North America Subcutaneous Immunoglobulins Revenue 2020-2031 (US$ Million)

Figure 30. North America Subcutaneous Immunoglobulins Sales Market Share by Purity (2020-2025)

Figure 31. North America Subcutaneous Immunoglobulins Sales Market Share by Application (2020-2025)

Figure 32. Asia-Pacific Subcutaneous Immunoglobulins Revenue 2020-2031 (US$ Million)

Figure 33. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Region (2020-2031)

Figure 34. Asia-Pacific Subcutaneous Immunoglobulins Revenue Market Share by Region (2020-2031)

Figure 35. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Purity (2020-2025)

Figure 36. Asia-Pacific Subcutaneous Immunoglobulins Sales Market Share by Application (2020-2025)

Figure 37. Europe Subcutaneous Immunoglobulins Revenue Growth Rate 2020-2031 (US$ Million)

Figure 38. Europe Subcutaneous Immunoglobulins Sales Market Share by Country (2020-2031)

Figure 39. Europe Subcutaneous Immunoglobulins Revenue Market Share by Country (2020-2031)

Figure 40. Europe Subcutaneous Immunoglobulins Sales Market Share by Purity (2020-2025)

Figure 41. Europe Subcutaneous Immunoglobulins Sales Market Share by Application (2020-2025)

Figure 42. Latin America Subcutaneous Immunoglobulins Revenue Growth Rate 2020-2031 (US$ Million)

Figure 43. Latin America Subcutaneous Immunoglobulins Sales Market Share by Country (2020-2031)

Figure 44. Latin America Subcutaneous Immunoglobulins Revenue Market Share by Country (2020-2025)

Figure 45. Latin America Subcutaneous Immunoglobulins Sales Market Share by Purity (2020-2025)

Figure 46. Latin America Subcutaneous Immunoglobulins Sales Market Share by Application (2020-2025)

Figure 47. Middle East and Africa Subcutaneous Immunoglobulins Revenue Growth Rate 2020-2031 (US$ Million)

Figure 48. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Purity (2020-2025)

Figure 51. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Application (2020-2025)

Figure 52. Subcutaneous Immunoglobulins Supply Chain (Upstream and Downstream Market)

Figure 53. Global Production Market Share of Subcutaneous Immunoglobulins Raw Materials by Region in 2024

Figure 54. Subcutaneous Immunoglobulins Distribution Channels

Figure 55. Global Subcutaneous Immunoglobulins Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 56. Global Subcutaneous Immunoglobulins Percentage 2020-2031: Online Sales VS Offline Sales

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Subcutaneous Immunoglobulins in 2025? zhanKai

The global market size of Subcutaneous Immunoglobulins in 2025 was 6087 Million USD.

Which companies rank high in the global Subcutaneous Immunoglobulins market? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Subcutaneous Immunoglobulins market size from 2025 to 2031? shouQi

What was the global market size of Subcutaneous Immunoglobulins in 2031? shouQi

Related Reports

Global Subcutaneous Immunoglobulins Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Subcutaneous Immunoglobulins market size was US$ 6087 million in 2025 and is forecast to reach a readjusted size of US$ 13360 million by 2032 with a CAGR of 12.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 65
USD 4250.00
(Single User License)
Global Subcutaneous Immunoglobulins Market Research Report 2026
The global Subcutaneous Immunoglobulins market was valued at US$ 6087 million in 2025 and is anticipated to reach US$ 13360 million by 2032, at a CAGR of 12.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 103
USD 2900.00
(Single User License)
Subcutaneous Immunoglobulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Subcutaneous Immunoglobulins was estimated to be worth US$ 6087 million in 2025 and is projected to reach US$ 13360 million, growing at a CAGR of 12.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 80
USD 3950.00
(Single User License)
Global Subcutaneous Immunoglobulins Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Subcutaneous Immunoglobulins market is projected to grow from US$ 5491 million in 2024 to US$ 12050 million by 2031, at a CAGR of 12.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 125
USD 4900.00
(Single User License)
Global Subcutaneous Immunoglobulins Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Subcutaneous Immunoglobulins market size was US$ 5491 million in 2024 and is forecast to a readjusted size of US$ 12050 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 70
USD 4250.00
(Single User License)
Subcutaneous Immunoglobulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Subcutaneous Immunoglobulins was estimated to be worth US$ 5491 million in 2024 and is forecast to a readjusted size of US$ 12050 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 90
USD 3950.00
(Single User License)
Global Subcutaneous Immunoglobulins Market Research Report 2025
The global market for Subcutaneous Immunoglobulins was valued at US$ 5491 million in the year 2024 and is projected to reach a revised size of US$ 12050 million by 2031, growing at a CAGR of 12.1% during the forecast period.
Published Date: 2025-01-16
Pages: 73
USD 2900.00
(Single User License)
Global Subcutaneous Immunoglobulins Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published Date: 2024-04-17
Pages: 121
USD 5600.00
(Single User License)
Global Subcutaneous Immunoglobulins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published Date: 2024-04-16
Pages: 128
USD 5900.00
(Single User License)
Global Subcutaneous Immunoglobulins Market Insights, Forecast to 2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published Date: 2024-04-07
Pages: 70
USD 4900.00
(Single User License)

Global Subcutaneous Immunoglobulins Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Subcutaneous Immunoglobulins market size was US$ 6087 million in 2025 and is forecast to reach a readjusted size of US$ 13360 million by 2032 with a CAGR of 12.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 65
USD 4250.00 (Single User License)
Global Subcutaneous Immunoglobulins Market Research Report 2026
The global Subcutaneous Immunoglobulins market was valued at US$ 6087 million in 2025 and is anticipated to reach US$ 13360 million by 2032, at a CAGR of 12.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 103
USD 2900.00 (Single User License)
Subcutaneous Immunoglobulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Subcutaneous Immunoglobulins was estimated to be worth US$ 6087 million in 2025 and is projected to reach US$ 13360 million, growing at a CAGR of 12.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 80
USD 3950.00 (Single User License)
Global Subcutaneous Immunoglobulins Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Subcutaneous Immunoglobulins market is projected to grow from US$ 5491 million in 2024 to US$ 12050 million by 2031, at a CAGR of 12.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 125
USD 4900.00 (Single User License)
Global Subcutaneous Immunoglobulins Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Subcutaneous Immunoglobulins market size was US$ 5491 million in 2024 and is forecast to a readjusted size of US$ 12050 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 70
USD 4250.00 (Single User License)
Subcutaneous Immunoglobulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Subcutaneous Immunoglobulins was estimated to be worth US$ 5491 million in 2024 and is forecast to a readjusted size of US$ 12050 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 90
USD 3950.00 (Single User License)
Global Subcutaneous Immunoglobulins Market Research Report 2025
The global market for Subcutaneous Immunoglobulins was valued at US$ 5491 million in the year 2024 and is projected to reach a revised size of US$ 12050 million by 2031, growing at a CAGR of 12.1% during the forecast period.
Published: 2025-01-16
Pages: 73
USD 2900.00 (Single User License)
Global Subcutaneous Immunoglobulins Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published: 2024-04-17
Pages: 121
USD 5600.00 (Single User License)
Global Subcutaneous Immunoglobulins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published: 2024-04-16
Pages: 128
USD 5900.00 (Single User License)
Global Subcutaneous Immunoglobulins Market Insights, Forecast to 2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published: 2024-04-07
Pages: 70
USD 4900.00 (Single User License)